Autoinjector + EVOLOCUMAB for hyperlipoproteinemias

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Sep 2026: Trial registered, NCT07803679

The trials

NCT07803679: A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma

State
Not started
Phase
Phase 4
People
308 planned
Started
31 Jan 2027
Primary completion
30 Apr 2029
Arms
Evolocumab and Routine Lipid Management
Results
None posted
  1. 4 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.